A Food and Drug Administration-approved Asthma Therapeutic Agent Impacts Amyloid β in the Brain in a Transgenic Model of Alzheimer Disease*. The Journal of Biological Chemistry; doi: 10.1074/jbc.M114.586602. Yukiko Hori, Shuko Takeda, Hansang Cho, Susanne Wegmann, Timothy M. Shoup, Kazue Takahashi, Daniel Irimia, David R. Elmaleh, Bradley T. Hyman and Eloise Hudry (2015)
The Journal of Biological Chemistry; doi: 10.1074/jbc.M114.586602.
